Ocular infections:

Indications for: VITRASERT

Treatment of cytomegalovirus (CMV) retinitis in patients with AIDS.

Adults and Children:

<9yrs: not recommended. ≥9yrs: Implant designed to release drug over 5–8 months. May be removed and replaced following depletion of ganciclovir.

VITRASERT Contraindications:

External infection. Severe thrombocytopenia.

VITRASERT Warnings/Precautions:

Should be administered by surgeon who has observed or assisted in surgical implantation of Vitrasert prior to attempting procedure. Monitor for extraocular CMV disease. Ophthalmologic follow-up advised at appropriate intervals. Pregnancy (Cat.C). Nursing mothers: not recommended.

VITRASERT Classification:

Nucleoside analogue.

Adverse Reactions:

Visual acuity loss of 3 lines or more, vitreous hemorrhage, retinal detachments, cataract formation/lens opacities, macular abnormalities, intraocular pressure spikes, optic disk/nerve changes, hyphemas, uveitis.

How Supplied: